---
layout: post
title: 'USAN Watch: May 2013'
date: '2013-05-12T08:07:00.002+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-05-13T09:27:00.965+01:00'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-5467312047943570272
blogger_orig_url: http://chembl.blogspot.com/2013/05/usan-watch-may-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for May 2013 have recently been published.</span><br />
<span class="Apple-style-span" style="font-family: inherit;"><br /></span>
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b>InChIKey (Parent)</b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/astodrimer.pdf">astodrimer</a>, <a href="http://www.ama-assn.org/resources/doc/usan/astodrimer-sodium.pdf">astodrimer sodium</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">SP-7013, NIH-6436, BRI-7013</span></span></div>
</div>
</div>
</td><td>n/a</td><td>therapeutic</td><td>synthetic small molecule</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/buparlisib.pdf">buparlisib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/buparlisib-hydrochloride.pdf">buparlisib hydrochloride</a></td><td>BKM-120</td><td>CWHUFRVAEUJCEF-UHFFFAOYSA-N</td><td>therapeutic</td><td>synthetic small molecule</td><td>PI3K</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/caplacizumab.pdf">caplacizumab</a></td><td>ALX-81</td><td>n/a</td><td>therapeutic</td><td>monoclonal antibody</td><td>factor VIII</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dasiprotimut-t.pdf">dasiprotimut T</a></td><td>Biovax ID</td><td>n/a</td><td>therapeutic</td><td>immunotherapeutic</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/esketamine.pdf">esketamine</a></td><td></td><td>YQEZLKZALYSWHR-ZDUSSCGKSA-N</td><td>therapeutic</td><td>synthetic small molecule</td><td>NMDAR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/fasiglifam.pdf">fasiglifam</a></td><td>TAK-875</td><td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td><td>therapeutic</td><td>synthetic small molecule</td><td>GPR40</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/florbetaben-f18.pdf">florbetaben F18</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">UNII-TLA7312TOI&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>imaging agent</td><td>synthetic small molecule</td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/macimorelin.pdf">macimorelin</a>, <a href="http://www.ama-assn.org/resources/doc/usan/macimorelin-acetate.pdf">macimorelin acetate</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">D-87575, EP-1572, ARD-07&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>diagnostic</td><td>synthetic small molecule</td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/mangofilcon-a.pdf">mangofilcon A</a></td><td></td><td>n/a</td><td>contact lens polymer</td><td>polymer</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ontuxizumab.pdf">ontuxizumab</a></td><td></td><td>n/a</td><td>therapeutic</td><td>monoclonal antibody</td><td>TEM-1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/parsatuzumab.pdf">parsatuzumab</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">RG-7414, anti-EGFL7 monoclonal antibody,
MEGF-0444A&nbsp;</span></span></div>
</div>
</div>
</td><td>n/a</td><td>therapeutic</td><td>monoclonal antibody</td><td>EGFL-7</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/perakizumab.pdf">perakizumab </a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">RG-4934, RO-5310074</span></span><span style="font-family: 'ArialMT'; font-size: 12.000000pt;">&nbsp;</span></div>
</div>
</div>
</td><td>n/a</td><td>therapeutic</td><td>monoclonal antibody</td><td>IL-17A</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pradigastat.pdf">pradigastat</a>, <a href="http://www.ama-assn.org/resources/doc/usan/pradigastat-sodium.pdf">pradigastat sodium</a></td><td>LCQ-908</td><td></td><td>therapeutic</td><td>synthetic small molecule</td><td>DGAT-1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/rimegepant.pdf">rimegepant</a>, <a href="http://www.ama-assn.org/resources/doc/usan/rimegepant-sulfate.pdf">rimegepant sulfate</a></td><td>BMS-927711</td><td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td><td>therapeutic</td><td>synthetic small molecule</td><td>CGRP-R</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/samfilcon-a.pdf">samfilcon A</a></td><td></td><td>n/a</td><td>contact lens polymer</td><td>polymer</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/topsalysin.pdf">topsalysin</a></td><td>PRX-302</td><td>n/a</td><td>therapeutic</td><td>protein</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vedotin.pdf">vedotin</a></td><td>PAB-MMAE</td><td></td><td>n/a</td><td>ADC component for monoclonal antibody</td><td>tubulin</td></tr>
</tbody></table>
